Literature DB >> 23374233

Psoriasis is associated with an increased risk of parkinsonism: a population-based 5-year follow-up study.

Jau-Jiuan Sheu1, Kuo-Hsien Wang, Herng-Ching Lin, Chung-Chien Huang.   

Abstract

BACKGROUND: Few studies have examined the association between autoimmune diseases and parkinsonism.
OBJECTIVE: We sought to investigate the risk for parkinsonism during a 5-year follow-up period after a diagnosis of psoriasis using a population-based data set in Taiwan.
METHODS: We identified 4885 patients with psoriasis for the study cohort and randomly selected 24,425 patients as a control cohort. Each subject was individually followed up for a 5-year period to identify those who subsequently developed parkinsonism.
RESULTS: Stratified Cox proportional hazards regression showed that the adjusted hazard ratio for parkinsonism during the 5-year follow-up period for patients with psoriasis was 1.74 (95% confidence interval 1.35-2.20) that of control patients. Furthermore, the adjusted hazard ratios for parkinsonism within the 5-year follow-up period after the index date for subjects with psoriasis were similar between both sexes (1.78 and 1.66 for men and women, respectively). LIMITATION: Our data set did not provide detailed information on the severity of psoriasis, or individual factors such as cigarette smoking, alcohol consumption, body mass index, and dietary patterns.
CONCLUSION: Patients with psoriasis were found to be at a significant risk of parkinsonism during a 5-year follow-up.
Copyright © 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23374233     DOI: 10.1016/j.jaad.2012.12.961

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

1.  High exposure compared with standard exposure to metoclopramide associated with a higher risk of parkinsonism: a nationwide population-based cohort study.

Authors:  Shin-Chia Tsai; Shiow-Yunn Sheu; Li-Nien Chien; Hsin-Chien Lee; Eunice Jia-Shiow Yuan; Rey-Yue Yuan
Journal:  Br J Clin Pharmacol       Date:  2018-06-19       Impact factor: 4.335

2.  Fatty Acid-Binding Protein 7 (FABP-7), Glutamic Acid and Neurofilament Light Chain (NFL) as Potential Markers of Neurodegenerative Disorders in Psoriatic Patients-A Pilot Study.

Authors:  Julia Nowowiejska; Anna Baran; Justyna Magdalena Hermanowicz; Beata Sieklucka; Julita Anna Krahel; Paulina Kiluk; Dariusz Pawlak; Iwona Flisiak
Journal:  J Clin Med       Date:  2022-04-26       Impact factor: 4.964

Review 3.  Psoriasis: classical and emerging comorbidities.

Authors:  Maria de Fátima Santos Paim de Oliveira; Bruno de Oliveira Rocha; Gleison Vieira Duarte
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

4.  Risk of Parkinson's Disease Among Patients with Psoriasis: A Systematic Review and Meta-analysis.

Authors:  Patompong Ungprasert; Narat Srivali; Wonngarm Kittanamongkolchai
Journal:  Indian J Dermatol       Date:  2016 Mar-Apr       Impact factor: 1.494

5.  Impact of Sjogren's syndrome on Parkinson's disease: A nationwide case-control study.

Authors:  Ming-Chi Wu; Xun Xu; Shan-Ming Chen; Yeu-Sheng Tyan; Jeng-Yuan Chiou; Yu-Hsun Wang; Li-Chi Lin; Chyong-Mei Chen; James Cheng-Chung Wei
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

6.  Neurodegenerative disorders, bullous pemphigoid and psoriasis: a comparative study in ethnic Poles indicates that Parkinson's disease is more relevant to bullous pemphigoid.

Authors:  Paweł Bartkiewicz; Justyna Gornowicz-Porowska; Paweł P Pietkiewicz; Anna Świrkowicz; Monika Bowszyc-Dmochowska; Marian Dmochowski
Journal:  Postepy Dermatol Alergol       Date:  2017-02-07       Impact factor: 1.837

Review 7.  Double trouble: psoriasis and cardiometabolic disorders.

Authors:  Nasrin Goolam Mahyoodeen; Nigel J Crowther; Mohammed Tikly
Journal:  Cardiovasc J Afr       Date:  2017-12-13       Impact factor: 1.167

Review 8.  Psoriasis and neurodegenerative diseases-a review.

Authors:  Julia Nowowiejska; Anna Baran; Iwona Flisiak
Journal:  Front Mol Neurosci       Date:  2022-09-26       Impact factor: 6.261

Review 9.  Parkinson disease and the immune system - associations, mechanisms and therapeutics.

Authors:  Eng-King Tan; Yin-Xia Chao; Andrew West; Ling-Ling Chan; Werner Poewe; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2020-04-24       Impact factor: 42.937

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.